Fingerprint
Dive into the research topics of 'Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
C4591007 Clinical Trial Group
Research output: Contribution to journal › Article › peer-review